学术前沿

肿瘤甲基化标志物研究进展&未来展望 | 《中国恶性肿瘤学科发展报告(2023)》

发布时间: 2024-09-19 浏览:

图片

【主编】

邢金良    空军军医大学

聂勇战    空军军医大学附属西京医院

曾木圣    中山大学肿瘤防治中心

谢晓冬    北部战区总医院


【副主编】

陈奎生    郑州大学第一附属医院

袁响林    华中科技大学同济医学院附属同济医院

王书奎    南京医科大学附属南京医院/南京市第一医院

宋现让    山东第一医科大学附属肿瘤医院

黄灿华    四川大学华西基础医学与法医学院

张媛媛    四川大学华西基础医学与法医学院

于文强    复旦大学生物医学研究院

吕   斌    南华大学

孙世权    西安交通大学公共卫生学院

缪洪明    陆军军医大学

杨   帆    重庆大学附属中心医院

李   伟    复旦大学生物医学研究院

葛圣阳    复旦大学生物医学研究院

谢   丽    山东第一医科大学附属肿瘤医院

黄启超    空军军医大学

席文文    南华大学


【编委】

葛圣阳    复旦大学生物医学研究院

吕艺蓁    西安交通大学公共卫生学院

孙晓东    四川大学华西基础医学与法医学院

周昕萌    四川大学华西基础医学与法医学院

廖青青    四川大学华西基础医学与法医学院

谢   娜    四川大学华西基础医学与法医学院

陈   瑶    重庆大学附属中心医院

黎   莉    重庆大学附属中心医院

冯天琳    重庆大学附属中心医院

郭   旭    空军军医大学

徐治洪    空军军医大学

参考文献(References)

[1] SUN Y,STRANSKY S,AGUILAN J,et al.High throughput and low bias DNA methylation and hydroxymethylation analysis by direct injection mass spectrometry[J].Anal Chim Acta,2021,1180:338880.

[2] MERKEL A,FERNáNDEZ⁃CALLEJO M,CASALS E,et al.gemBS:high throughput processing for DNA methylation data from bisulfite sequencing[J].Bioinformatics,2019,35(5):737⁃742.

[3] HAN Z W,MA F,ZHANG C Y.Methylation ⁃ sensitive transcription ⁃enhanced single molecule biosensing of DNA methylation in cancer cells and tissues[J].Anal Chim Acta,2023,1251:340996.

[4] HOSSEINI M,LOTFI ⁃ SHAHREZA M,NIKPOUR P. Integrative analysis of DNA methylation and gene expression through machine learning identifies stomach cancer diagnostic and prognostic bio⁃ markers[J].J Cell Mol Med,2023,27(5):714⁃726.

[5] XU W,XU M,WANG L,et al.Integrative analysis of DNA methylation and gene expression identified cervical cancer ⁃ specific diagnostic biomarkers[J].Signal Transduct Target Ther,2019,4:55.

[6] OOKI A,MALEKI Z,TSAY J J,et al.A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non ⁃ Small Cell Lung Cancer and Serum DNA[J].Clin Cancer Res,2017 23(22):7141⁃7152.

[7] IBRAHIM J ,PEETERS M ,VAN CAMP G ,et al. Methylation biomarkers for early cancer detection and diagnosis:Current and future perspectives[J].Eur J Cancer,2023,178:91⁃113.

[8] HONG S,LIN B,XU M,et al.Cell⁃free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma[J].EBioMedicine,2023,90:104497.

[9] XIE Y,LI P,SUN D,et al.DNA Methylation ⁃Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detec⁃tion of Colorectal Cancer[J].Cancer Res,2023,83(21):3636⁃3649.

[10] LI F,ZHENG Z,CHEN W,et al.Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms[J].Drug Resist Updat,2023,68:100938.

[11] SSBIZZERA M,DESCOTES F,ARBER T,et al.Bladder cancer detection in patients with neurogenic bladder:are cystoscopy and cytology effective,and are biomarkers pertinent as future diagnostic tools? A scoping review[J].World J Urol,2022,40(8):1897⁃1913

[12] WEVER B M M,VAN DEN HELDER R,VAN SPLUNTER A P,et al.DNA methylation testing for endometrial cancer detection in urine,cervicovaginal self ⁃ samples and cervical scrapes[J]. Int JCancer,2023,153(2):341⁃351.

[13] BAKKUM ⁃GAMEZ J N,SHERMAN M E,SLETTEDAHL S W,et al.Detection of endometrial cancer using tampon ⁃ based collection and methylated DNA markers[J].Gynecol Oncol,2023,174:11⁃20

[14] LI J,LI Y,LI W,et al.Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor ⁃immune surveillance networks[J].Genome Res,2019,29(2):270⁃280.

[15] DONG S,LI W,WANG L,et al.Histone⁃Related Genes Are Hyper⁃ methylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan ⁃Cancer Biomarker[J].Cancer Res,2019,79(24):6101⁃6112.

[16] DONG S,LU Q,XU P,et al.Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening[J].Clin Transl Med,2021,11(6):e457.

[17] CHENG J,SWARUP N,LI F,et al.Distinct Features of Plasma Ultrashort Single⁃Stranded Cell⁃Free DNA as Biomarkers for Lung Cancer Detection[J].Clin Chem,2023,69(11):1270⁃1282.

[18] SAURA C,ORTIZ C,MATITO J,et al.Early ⁃ Stage Breast Cancer Detection in Breast Milk[J].Cancer Discov,2023,13(10):2180⁃2191.

[19] STOECKLEIN N H,FLUEGEN G,GUGLIELMI R,et al.Ultra⁃sen⁃sitive CTC ⁃ based liquid biopsy for pancreatic cancer enabled by large blood volume analysis[J].Mol Cancer,2023,22(1):181.

[20] KO S Y,LEE W,WEIGERT M,et al.The glycoprotein CD147 de⁃ fines miRNA ⁃enriched extracellular vesicles that derive from can⁃cer cells[J].J Extracell Vesicles,2023,12(4):e12318.

[21] ZHAI C,XIE F,XU J,et al.Correlation between membrane pro⁃teins and sizes of extracellular vesicles and particles:A potential signature for cancer diagnosis[J]. J Extracell Vesicles,2023,12(12):e12391.

[22] RUI T,WANG K,XIANG A,et al.Serum Exosome⁃Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis[J].Int J Nano⁃medicine,2023,18:1989⁃2001.

[23] CARBONELL C,FRIGOLA J,PARDO N,et al.Dynamic changes in circulating tumor DNA assessed by shallow whole⁃genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC[J].Mol Oncol,2023,17(5):779⁃791.

[24] XUE K H,JIANG Y F,BAI J Y,et al.Melatonin suppresses Akt/mTOR/S6K activity,induces cell apoptosis,and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect[J].Redox Rep,2023,28(1):2251234.

[25] LI Y,TANG S,SHI X,et al.Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy⁃resistant pancreatic cancer[J].Cell Rep Med,2023,4(9):101162.

[26] YUAN T,ZHOU T,QIAN M,et al.SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ[J].Hepatology,2023,78(1):103⁃119.

[27] MILLER J J,GONZALEZ CASTRO L N,MCBRAYER S,et al.Isocitrate dehydrogenase(IDH)mutant gliomas:A Society for Neuro⁃Oncology(SNO)consensus review on diagnosis,management,and future directions[J].Neuro Oncol,2023,25(1):4⁃25.

[28] LYU J,LIU Y,GONG L,et al.Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance[J].Cancer Discov,2023,13(1):170⁃193.

[29] BROWN K,JENKINS L M M,CROOKS D R,et al.Targeting mutant p53⁃R248W reactivates WT p53 function and alters the onco⁃metabolic profile[J].Front Oncol,2023,12:1094210.

[30] MALHOTRA S,MIRAS M C M,PAPPOLLA A,et al.Liquid Biopsy in Neurological Diseases[J].Cells,2023,12(14):1911.

[31] DE RASMO D,CORMIO A,CORMIO G,et al.Ovarian Cancer:A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics[J].Int J Mol Sci,2023,24(2):1224.

[32] CHEN X,WEI C,HUANG L,et al.Non⁃coding RNAs regulate mito⁃chondrial dynamics in the development of gastric cancer[J].Front Mol Biosci,2023,10:1107651.

[33] FONTANA F,ANSELMI M,LIMONTA P.Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer[J].Cancers(Basel),2023,15(4):1192.

[34] LI S,HAN S,ZHANG Q,et al.FUNDC2 promotes liver tumorigenesis by inhibiting MFN1⁃mediated mitochondrial fusion[J].Nat Commun,2022,13(1):3486.

[35] WU J,DENG Z,ZHU Y,et al.Overexpression of miR⁃431⁃5p impairs mitochondrial function and induces apoptosis in gastric cancer cells via the Bax/Bcl⁃2/caspase3 pathway[J].Nan Fang Yi Ke Da Xue Xue Bao,2023,43(4):537⁃543.

[36] MENG H W,SHEN Z B,MENG X S,et al.Novel flavonoid 1,3,4⁃oxadiazole derivatives ameliorate MPTP ⁃ induced Parkinson's dis⁃ease via Nrf2 / NF ⁃ κB signaling pathway[J]. Bioorg Chem,2023,138:106654.

[37] HEISER C N,SIMMONS A J,REVETTA F,et al.Molecular cartog⁃raphy uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors[J].Cell,2023,186(25):5620⁃5637.

[38] LIN J R,WANG S,COY S,et al.Multiplexed 3D atlas of state tran⁃sitions and immune interaction in colorectal cancer[J].Cell,2023,186(2):363⁃381.

[39] MARUSYK A,ALMENDRO V,POLYAK K.Intra⁃tumour heteroge⁃neity:a looking glass for cancer?[J].Nat Rev Cancer,2012,12(5):323⁃334.

[40] EDITORIAL.A focus on single⁃cell omics[J].Nat Rev Genet,2023,24(8):485.

[41] ZENG Q,MOUSA M,NADUKKANDY A S,et al.Understanding tumour endothelial cell heterogeneity and function from single⁃cell omics[J].Nat Rev Cancer,2023,23(8):544⁃564.

[42] SO W V,DEJARDIN D,ROSSMANN E,et al.Predictive biomarkers for PD⁃1/PD⁃L1 checkpoint inhibitor response in NSCLC:an analysis of clinical trial and real⁃world data[J].J Immunother Cancer,2023,11(2):e006464.

[43] ZHANG R,WANG J,DU Y,et al.CDK5 destabilizes PD ⁃ L1 via chaperon⁃mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma[J].J Immunother Cancer,2023,11(11):e007529.

[44] DEUTSCH J S,LAI J,SCHENK K M,et al.Immune microenvironment of basal cell carcinoma and tumor regression following combined PD⁃1/LAG⁃3 blockade[J].J Immunother Cancer,2023,11(12):e007463.

[45] SABERZADEH⁃ARDESTANI B,GRAHAM R P,MCMAHON S,et al.Immune Marker Spatial Distribution and Clinical Outcome after PD⁃1 Blockade in Mismatch Repair⁃deficient,Advanced Colorectal Carcinomas[J].Clin Cancer Res,2023,29(20):4268⁃4277.

[46] GONZALEZ⁃MUNOZ T,DI GIANNATALE A,GARCIA⁃SILVA S,et al.Endoglin,a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis[J].Clin Cancer Res,2023,29(18):3744⁃3758.

[47] ZHU Q,XU H,HUANG L,et al. Identification and detection of plasma extracellular vesicles ⁃ derived biomarkers for esophageal squamous cell carcinoma diagnosis[J].Biosens Bioelectron,2023,225:115088.

[48] LIEN H E,BERG H F,HALLE M K,et al.Single⁃cell profiling of low ⁃ stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease[J].EBioMedicine,2023,92:104595.

[49] MARTIN A,EPIFANO C,VILAPLANA⁃MARTI B,et al.Mitochondrial RNA methyltransferase TRMT61B is a new,potential biomarker and therapeutic target for highly aneuploid cancers[J].Cell Death Differ,2023,30(1):37⁃53.

[50] TAYLOR M S,WU C,FRIDY P C,et al.Ultrasensitive Detection of Circulating LINE⁃1 ORF1p as a Specific Multicancer Biomarker[J].Cancer Discov,2023,13(12):2532⁃2547.

[51] YU H,SHI T,YAO L,et al. Elevated nuclear PIGL disrupts the cMyc/BRD4 axis and improves PD⁃1 blockade therapy by dampening tumor immune evasion[J].Cell Mol Immunol,2023,20(8):867⁃880.

[52] YU Q,FU W,FU Y,et al.BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours[J].Mol Cancer,2023,22(1):143.

[53] ZHU X,SU Q,XIE H,et al.SIRT1 deacetylates WEE1 and sensitizes cancer cells to WEE1 inhibition[J].Nat Chem Biol,2023,19(5):585⁃595.

[54] PLAZA A,PASTOR⁃FERNANDEZ A,LOPEZ⁃ACEITUNO J L,et al. p21 is necessary for the beneficial effects of fasting during chemotherapy[J].Cancer Commun(Lond),2023,43(1):164⁃168.

[55] ZHENG X,LUO Y,XIONG Y,et al.Tumor cell⁃intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1⁃STAT1 pathway[J].J Immunother Cancer,2023,11(12):e007678.

[56] SON J A,WEON J H,BAEK G O,et al.Circulating small extracellular vesicle⁃derived splicing factor 3b subunit 4 as a non⁃invasive diagnostic biomarker of early hepatocellular carcinoma[J].J Exp Clin Cancer Res,2023,42(1):288.

[57] BARTH D A,MOIK F,STEINLECHNER S,et al.Early kinetics of C reactive protein for cancer⁃agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors:a multicenter cohort study[J].J Immunother Cancer,2023,11(12):

e007765.

[58] DANTAS E,MURTHY A,AHMED T,et al.TIMP1 is an early biomarker for detection and prognosis of lung cancer[J]. Clin Transl Med,2023,13(10):e1391.

[59] HUBERS C,ABDUL PARI A A,GRIESHOBER D,et al.Primary tumor ⁃ derived systemic nANGPTL4 inhibits metastasis[J].J Exp Med,2023,220(1):e20202595.

[60] JIANG C,KUMAR A,YU Z,et al.Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor[J].J Clin Invest,2023,133(12):e168227.

[61] MUNSON P V,ADAMIK J,HARTMANN F J,et al.Polyunsaturated Fatty Acid⁃Bound alpha⁃Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism[J]. Cancer Res,2023,83(9):1543⁃1557.

[62] NISMAN B,OLEINIKOV K,NECHUSHTAN H,et al. Plasma Progastrin⁃Releasing Peptide and Chromogranin A Assays for Diag⁃nosing and Monitoring Lung Well ⁃ Differentiated Neuroendocrine Tumors:A Brief Report[J].J Thorac Oncol,2023,18(3):369⁃376.

[63] SHI J,ZHOU M,ZHOU X,et al.Multi⁃omics and case⁃control analyses identify immunoglobulin M as a tumour ⁃ derived serum biomarker of ocular adnexal extranodal marginal zone lymphoma[J]. Clin Transl Med,2023,13(5):e1259.

[64] BIAN X,JIANG H,MENG Y,et al.Regulation of gene expression by glycolytic and gluconeogenic enzymes[J]. Trends Cell Biol,2022,32(9):786⁃799.

[65] WU D,LI Z,ZHANG Y,et al.Proline uptake promotes activation of lymphoid tissue inducer cells to maintain gut homeostasis[J].Nat Metab,2023,5(11):1953⁃1968.

[66] XUE Y,LU F,CHANG Z,et al.Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade[J].Nat Commun,2023,14(1):4758.

[67] DE FALCO P,LAZZARINO G,FELICE F,et al.Hindering NAT8L expression in hepatocellular carcinoma increases cytosolic aspartate delivery that fosters pentose phosphate pathway and purine biosynthesis promoting cell proliferation[J].Redox Biol,2023,59:102585.

[68] HU J,ZHANG Z,HU H,et al.LRH⁃1 activation alleviates diabetes⁃induced podocyte injury by promoting GLS2⁃mediated glutaminolysis[J].Cell Prolif,2023,56(11):e13479.

[69] YANG S,JIN S,XIAN H,et al.Metabolic enzyme UAP1 mediates IRF3 pyrophosphorylation to facilitate innate immune response[J].Mol Cell,2023,83(2):298⁃313.

[70] ZOU S,QIN B,YANG Z,et al.CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer[J].Cancer Res,2023,83(3):414⁃427.

[71] NICASTRO R,BROHEE L,ALBA J,et al.Malonyl⁃CoA is a conserved endogenous ATP⁃competitive mTORC1 inhibitor[J].Nat Cell Biol,2023,25(9):1303⁃1318.

[72] TANG T,HUANG X,LU M,et al.Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor⁃autonomous and ⁃autocrine manner[J].Nat Commun,2023,14(1):3364.

[73] CHEU J W,CHIU D K,KWAN K K,et al.Hypoxia⁃inducible factor orchestrates adenosine metabolism to promote liver cancer develop⁃ment[J].Sci Adv,2023,9(18):eade5111.

[74] KOWASH R R,AKBAY E A.Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer[J].Front Immunol,2023,14:1130358.

-  END  -


图片


在线咨询
400电话
021-64398978
微信咨询
微信咨询
立即扫码加我微信
售后服务